First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Vaccination allows Genex case managers more opportunities for vital interaction to improve case outcomesAs frontline workers, field case m
December 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.
How the World (May Be) Forever Changed by COVID-19 One year ago this week, our Company sent out the first set of employee notices to adop
It has been a year since the United States and Canada first felt the effects of COVID-19.
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
As 2020 began, a persistent opioid overdose epidemic was near the forefront of a list of national concerns in the United States.